Royalty Pharma plc
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $618.7M | $929.0M | $477.0M | $1.71B | $1.54B | $1.01B | $246.2M | $1.92B |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $1.53B | $1.80B | $1.27B | $2.55B | $2.88B | $2.70B | $832.1M | — |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | $924.6M | $0 | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | $0 | $5.7M | $28.7M | $51.7M | — |
| Total Assets | $19.62B | $18.22B | $16.38B | $16.81B | $17.52B | $16.02B | $12.45B | — |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $636.2M | $1.25B | $161.4M | $1.17B | $171.3M | $307.9M | $333.4M | — |
| Long-Term Debt | $8.57B | $6.61B | $6.14B | $6.12B | $7.10B | $5.82B | $5.96B | — |
| Total Liabilities | $9.91B | $7.88B | $6.30B | $7.29B | $7.27B | $6.12B | $6.31B | — |
| Stockholders' Equity | ||||||||
| Retained Earnings | $2.36B | $2.85B | $2.52B | $1.96B | $2.26B | $1.92B | $2.83B | — |
| Total Stockholders' Equity | $9.71B | $10.34B | $10.08B | $9.53B | $10.25B | $9.90B | $6.14B | $4.55B |
All I want to know is where I'm going to die so I'll never go there.